Section Arrow
Quote
PTGX.NASDAQ
- Protagonist Therapeutics
Quotes are at least 15-min delayed:2025/11/16 02:45 EST
Regular Hours
Last
 84.61
+1.37 (+1.65%)
Day High 
85.9 
Prev. Close
83.24 
1-M High
86.9 
Volume 
755.43K 
Bid
82.15
Ask
86.63
Day Low
82.06 
Open
82.18 
1-M Low
73.08 
Market Cap 
5.20B 
Currency USD 
P/E 126.58 
%Yield -- 
10-SMA 80.52 
20-SMA 78.25 
50-SMA 70.57 
52-W High 93.2499 
52-W Low 33.31 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.66/-1.30
Enterprise Value
5.21B
Balance Sheet
Book Value Per Share
10.32
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
60.00M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed：2025/11/16 02:45 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.